FXAIX | MIVIX | FXAIX / MIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 4 years | - |
Gain YTD | 20.776 | 15.534 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 585B | 429M | 136,364% |
Annual Yield % from dividends | 1.31 | 0.40 | 328% |
Returns for 1 year | 33.63 | 17.47 | 193% |
Returns for 3 years | 37.19 | 10.37 | 359% |
Returns for 5 years | 104.21 | N/A | - |
Returns for 10 years | 212.82 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SNTKX | 26.18 | N/A | N/A |
Steward International Enhanced Index A | |||
FBTAX | 34.26 | -0.05 | -0.15% |
Fidelity Advisor Biotechnology A | |||
PLFIX | 28.11 | -0.06 | -0.21% |
Principal Large Cap S&P 500 Index Inst | |||
AGFGX | 13.10 | -0.06 | -0.46% |
American Century Focused Global Gr R5 | |||
RESCX | 8.73 | -0.05 | -0.57% |
HSBC Radiant US Smaller Companies I |